Startup company founded by Washington University scientists acquired by Eli Lilly
Pharmaceutical maker Eli Lilly and Company has purchased Disarm Therapeutics, a startup biotechnology firm founded by researchers at Washington University
Read more
Drug-therapy combo cuts breast cancer recurrence risk by 25%, Eli Lilly announces
Colon cancer cases on the rise for people under 50, doctors say While colon cancer isn’t often diagnosed in those
Read more